• Home > Publications
  • Feature HDAC1 and HDAC7 as novel targets ofmiR-34a in breast cancer uncovered by deacetylation of HSP70 K246.
    Application WB
    Species Homo sapiens
    Targets HSP70
    Title MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer
    Publication Ray-ChangWu, Cancer Lett, 2014
    Methods K246 acetylation-specificantibodies were generated by immunizing rabbits with FVEE(Ac-K)RKHKK peptide,affinity purified and titered (service by Abmart).